Cellular signaling by double-stranded RNA will be investigated in this project. DsRNA is a potent regulator of enzyme activation and transcriptional signaling. Its cellular actions are connected to the functioning of the interferon system and often it is a mediator of the cellular responses to virus infection. Its identity as a marker of viral infection has been reinforced by the recent discovery of its receptor, the Toll-like receptor 3 (TLR3), which is a component of the innate immune system that responds to various infectious agents. Additional interests in the biological actions of dsRNA have risen from the increasing usage of siRNA, which are short dsRNAs, as an experimental tool. The overall objective of our project is to identify the repertoire of human genes induced by activation of the innate immune system by dsRNA and viruses and to delineate the corresponding signaling pathways using biochemical and genetic tools. Specifically, we will analyze the convergent and divergent pathways used by dsRNA, Sendai virus and interferons to induce transcription of overlapping sets of genes For this purpose, we will use microarray analyses of genes induced by the above agents in various mutant cell lines defective in known components of relevant signaling pathways. We will determine the biochemical basis of the newly observed need of tyrosine phosphorylation of TLR3 in mediating signals generated by dsRNA. We will also investigate the biochemical, cellular and physiological functions of PACT, the protein activator of the multi-functional protein kinase, PKR, an intracellular receptor of dsRNA. A possible role of PACT in mediating innate immune responses through TLRs will also be investigated. Successful completion of the proposed project will lead to a better understanding of the mechanism of action of the mammalian innate immune system and how it regulates host-virus interactions and cell growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA062220-14
Application #
7614431
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
14
Fiscal Year
2008
Total Cost
$488,497
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Herjan, Tomasz; Hong, Lingzi; Bubenik, Jodi et al. (2018) IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol 19:354-365
Veleeparambil, Manoj; Poddar, Darshana; Abdulkhalek, Samar et al. (2018) Constitutively Bound EGFR-Mediated Tyrosine Phosphorylation of TLR9 Is Required for Its Ability To Signal. J Immunol 200:2809-2818
Nan, Jing; Wang, Yuxin; Yang, Jinbo et al. (2018) IRF9 and unphosphorylated STAT2 cooperate with NF-?B to drive IL6 expression. Proc Natl Acad Sci U S A 115:3906-3911
Sarvestani, Samaneh K; Signs, Steven A; Lefebvre, Veronique et al. (2018) Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. Oncotarget 9:28717-28730
Cai, Gang; Zhu, Liang; Chen, Xing et al. (2018) TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation. Proc Natl Acad Sci U S A 115:11531-11536
Zhou, Hao; Bulek, Katarzyna; Li, Xiao et al. (2017) IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs. Elife 6:
Wang, Chenhui; Zhang, Cun-Jin; Martin, Bradley N et al. (2017) IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression. Nat Commun 8:15508
Wang, Yuxin; Nan, Jing; Willard, Belinda et al. (2017) Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387. EMBO J 36:202-212
Doherty, Mary R; Cheon, HyeonJoo; Junk, Damian J et al. (2017) Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proc Natl Acad Sci U S A 114:13792-13797
Liu, Caini; Zhu, Liang; Fukuda, Koichi et al. (2017) The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo. Sci Signal 10:

Showing the most recent 10 out of 253 publications